Tokyo, Japan and Cambridge, UK, 31 October 2025 - Nxera Pharma ("the Company" or "Nxera"; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third qua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback